BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lewnard JA, Lo NC, Arinaminpathy N, Frost I, Laxminarayan R. Childhood vaccines and antibiotic use in low- and middle-income countries. Nature 2020;581:94-9. [PMID: 32376956 DOI: 10.1038/s41586-020-2238-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Z, Zhang Q, Wang T, Xu N, Lu T, Hong W, Penuelas J, Gillings M, Wang M, Gao W, Qian H. Assessment of global health risk of antibiotic resistance genes. Nat Commun 2022;13:1553. [PMID: 35322038 DOI: 10.1038/s41467-022-29283-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
2 Ozawa S, Chen HH, Rao GG, Eguale T, Stringer A. Value of pneumococcal vaccination in controlling the development of antimicrobial resistance (AMR): Case study using DREAMR in Ethiopia. Vaccine 2021;39:6700-11. [PMID: 34538697 DOI: 10.1016/j.vaccine.2021.04.024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Godman B, Egwuenu A, Haque M, Malande OO, Schellack N, Kumar S, Saleem Z, Sneddon J, Hoxha I, Islam S, Mwita J, do Nascimento RCRM, Dias Godói IP, Niba LL, Amu AA, Acolatse J, Incoom R, Sefah IA, Opanga S, Kurdi A, Chikowe I, Khuluza F, Kibuule D, Ogunleye OO, Olalekan A, Markovic-Pekovic V, Meyer JC, Alfadl A, Phuong TNT, Kalungia AC, Campbell S, Pisana A, Wale J, Seaton RA. Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. Life (Basel) 2021;11:528. [PMID: 34200116 DOI: 10.3390/life11060528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lemoine C, Thakur A, Krajišnik D, Guyon R, Longet S, Razim A, Górska S, Pantelić I, Ilić T, Nikolić I, Lavelle EC, Gamian A, Savić S, Milicic A. Technological Approaches for Improving Vaccination Compliance and Coverage. Vaccines (Basel) 2020;8:E304. [PMID: 32560088 DOI: 10.3390/vaccines8020304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
5 Andrejko K, Ratnasiri B, Hausdorff WP, Laxminarayan R, Lewnard JA. Antimicrobial resistance in paediatric Streptococcus pneumoniae isolates amid global implementation of pneumococcal conjugate vaccines: a systematic review and meta-regression analysis. Lancet Microbe 2021;2:e450-60. [PMID: 34485957 DOI: 10.1016/S2666-5247(21)00064-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Andrejko K, Ratnasiri B, Lewnard JA. Association of pneumococcal serotype with susceptibility to antimicrobial drugs: a systematic review and meta-analysis. Clin Infect Dis 2021:ciab852. [PMID: 34599811 DOI: 10.1093/cid/ciab852] [Reference Citation Analysis]
7 Enane LA, Christenson JC. Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens. Paediatr Int Child Health 2021;41:65-75. [PMID: 33305992 DOI: 10.1080/20469047.2020.1853350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Magez S, Li Z, Nguyen HTT, Pinto Torres JE, Van Wielendaele P, Radwanska M, Began J, Zoll S, Sterckx YG. The History of Anti-Trypanosome Vaccine Development Shows That Highly Immunogenic and Exposed Pathogen-Derived Antigens Are Not Necessarily Good Target Candidates: Enolase and ISG75 as Examples. Pathogens 2021;10:1050. [PMID: 34451514 DOI: 10.3390/pathogens10081050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Álvarez García FJ, Cilleruelo Ortega MJ, Álvarez Aldeán J, Garcés-sánchez M, Garrote Llanos E, Iofrío de Arce A, Montesdeoca Melián A, Navarro Gómez ML, Pineda Solas V, Rivero Calle I, Ruiz-contreras J, Serrano Marchuet P. Immunization schedule of the Pediatric Spanish Association: 2022 recommendations. Anales de Pediatría (English Edition) 2022. [DOI: 10.1016/j.anpede.2021.11.002] [Reference Citation Analysis]
10 Lewnard JA, Patel MM, Jewell NP, Verani JR, Kobayashi M, Tenforde MW, Dean NE, Cowling BJ, Lopman BA. Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines. Epidemiology 2021;32:508-17. [PMID: 34001753 DOI: 10.1097/EDE.0000000000001366] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
11 Lewnard JA. Uses of pathogen detection data to estimate vaccine direct effects in case-control studies. J R Soc Interface 2020;17:20200161. [PMID: 32781936 DOI: 10.1098/rsif.2020.0161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Laxminarayan R. The overlooked pandemic of antimicrobial resistance. The Lancet 2022. [DOI: 10.1016/s0140-6736(22)00087-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
13 Lynn DJ, Benson SC, Lynn MA, Pulendran B. Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms. Nat Rev Immunol 2021. [PMID: 34002068 DOI: 10.1038/s41577-021-00554-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Birger R, Antillón M, Bilcke J, Dolecek C, Dougan G, Pollard AJ, Neuzil KM, Frost I, Laxminarayan R, Pitzer VE. Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study. The Lancet Infectious Diseases 2022;22:679-91. [DOI: 10.1016/s1473-3099(21)00627-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
15 Hall EW, Tippett A, Fridkin S, Anderson EJ, Lopman B, Benkeser D, Baker JM. Association Between Rotavirus Vaccination and Antibiotic Prescribing Among Commercially Insured US Children, 2007-2018. Open Forum Infect Dis 2022;9:ofac276. [PMID: 35855006 DOI: 10.1093/ofid/ofac276] [Reference Citation Analysis]
16 Holm M, Zellweger RM, Poudyal N, Smith KH, Joh HS, Marks F. Measuring the Link Between Vaccines and Antimicrobial Resistance in Low Resource Settings – Limitations and Opportunities in Direct and Indirect Assessments and Implications for Impact Studies. Front Trop Dis 2022;3:805833. [DOI: 10.3389/fitd.2022.805833] [Reference Citation Analysis]
17 Bromham L, Skeels A, Schneemann H, Dinnage R, Hua X. There is little evidence that spicy food in hot countries is an adaptation to reducing infection risk. Nat Hum Behav 2021;5:878-91. [PMID: 33542529 DOI: 10.1038/s41562-020-01039-8] [Reference Citation Analysis]
18 Schueller E, Nandi A, Joshi J, Laxminarayan R, Klein EY. Associations between private vaccine and antimicrobial consumption across Indian states, 2009-2017. Ann N Y Acad Sci 2021;1494:31-43. [PMID: 33547650 DOI: 10.1111/nyas.14571] [Reference Citation Analysis]
19 Cable J, Rappuoli R, Klemm EJ, Kang G, Mutreja A, Wright GJ, Pizza M, Castro SA, Hoffmann JP, Alter G, Carfi A, Pollard AJ, Krammer F, Gupta RK, Wagner CE, Machado V, Modjarrad K, Corey L, B Gilbert P, Dougan G, Lurie N, Bjorkman PJ, Chiu C, Nemes E, Gordon SB, Steer AC, Rudel T, Blish CA, Sandberg JT, Brennan K, Klugman KP, Stuart LM, Madhi SA, Karp CL. Innovative vaccine approaches-a Keystone Symposia report. Ann N Y Acad Sci 2022. [PMID: 35029310 DOI: 10.1111/nyas.14739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Brennhofer SA, Platts-Mills JA, Lewnard JA, Liu J, Houpt ER, Rogawski McQuade ET. Antibiotic use attributable to specific aetiologies of diarrhoea in children under 2 years of age in low-resource settings: a secondary analysis of the MAL-ED birth cohort. BMJ Open 2022;12:e058740. [PMID: 35365541 DOI: 10.1136/bmjopen-2021-058740] [Reference Citation Analysis]
21 Oldenkamp R, Schultsz C, Mancini E, Cappuccio A. Filling the gaps in the global prevalence map of clinical antimicrobial resistance. Proc Natl Acad Sci U S A 2021;118:e2013515118. [PMID: 33372157 DOI: 10.1073/pnas.2013515118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 [DOI: 10.1101/2021.06.23.21259415] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Ramalingam V, Rajaram R, Archunan G, Padmanabhan P, Gulyás B. Structural Characterization, Antimicrobial, Antibiofilm, Antioxidant, Anticancer and Acute Toxicity Properties of N-(2-hydroxyphenyl)-2-phenazinamine From Nocardiopsis exhalans (KP149558). Front Cell Infect Microbiol 2022;12:794338. [DOI: 10.3389/fcimb.2022.794338] [Reference Citation Analysis]
24 Sluggett JK, Moldovan M, Lang C, Lynn DJ, Papanicolas LE, Crotty M, Whitehead C, Rogers GB, Wesselingh SL, Inacio MC. Contribution of facility level factors to variation in antibiotic use in long-term care facilities: a national cohort study. J Antimicrob Chemother 2021;76:1339-48. [PMID: 33580681 DOI: 10.1093/jac/dkab007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Iyer S, Yadav R, Agarwal S, Tripathi S, Agarwal R. Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases. Clin Microbiol Rev 2021;:e0012321. [PMID: 34788128 DOI: 10.1128/CMR.00123-21] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Huang X, Zhang X, Zhang K, Xue X, Xiong J, Huang Y, Zhang D, Zhang J, Zhang Z, Yan F. Defect-mediated Z-scheme carriers’ dynamics of C-ZnO/A-CN toward highly enhanced photocatalytic TC degradation. Journal of Alloys and Compounds 2021;877:160321. [DOI: 10.1016/j.jallcom.2021.160321] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
27 Zheng D, Yin G, Liu M, Hou L, Yang Y, Liu X, Jiang Y, Chen C, Wu H. Metagenomics highlights the impact of climate and human activities on antibiotic resistance genes in China's estuaries. Environmental Pollution 2022;301:119015. [DOI: 10.1016/j.envpol.2022.119015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
28 Sun X, Wang D, Ding L, Xu Y, Qi W, Zhao D, Liu L, Yin C, Cui C, Wang Z, Sun L, Sun L. Activation of Autophagy Through the NLRP3/mTOR Pathway: A Potential Mechanism for Alleviation of Pneumonia by QingFei Yin. Front Pharmacol 2021;12:763160. [PMID: 35111047 DOI: 10.3389/fphar.2021.763160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Ni J, Liu D, Wang W, Wang A, Jia J, Tian J, Xing Z. Hierarchical defect-rich flower-like BiOBr/Ag nanoparticles/ultrathin g-C3N4 with transfer channels plasmonic Z-scheme heterojunction photocatalyst for accelerated visible-light-driven photothermal-photocatalytic oxytetracycline degradation. Chemical Engineering Journal 2021;419:129969. [DOI: 10.1016/j.cej.2021.129969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Álvarez García FJ, Cilleruelo Ortega MJ, Álvarez Aldeán J, Garcés-Sánchez M, García Sánchez N, Garrote Llanos E, Hernández Merino Á, Iofrío de Arce A, Montesdeoca Melián A, Navarro Gómez ML, Ruiz-Contreras J; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). [Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations]. An Pediatr (Engl Ed) 2021;94:53.e1-53.e10. [PMID: 33419517 DOI: 10.1016/j.anpedi.2020.10.002] [Reference Citation Analysis]
31 Godman B, Egwuenu A, Wesangula E, Schellack N, Kalungia AC, Tiroyakgosi C, Kgatlwane J, Mwita JC, Patrick O, Niba LL, Amu AA, Oguntade RT, Alabi ME, Ncube NB, Sefah IA, Acolatse J, Incoom R, Guantai AN, Oluka M, Opanga S, Chikowe I, Khuluza F, Chiumia FK, Jana CE, Kalemeera F, Hango E, Fadare J, Ogunleye OO, Ebruke BE, Meyer JC, Massele A, Malande OO, Kibuule D, Kapona O, Zaranyika T, Bwakura-dangarembizi M, Kujinga T, Saleem Z, Kurdi A, Shahwan M, Jairoun AA, Wale J, Brink AJ. Tackling antimicrobial resistance across sub-Saharan Africa; current challenges and implications for the future. Expert Opinion on Drug Safety. [DOI: 10.1080/14740338.2022.2106368] [Reference Citation Analysis]
32 Lewnard JA, Rogawski McQuade ET, Platts-Mills JA, Kotloff KL, Laxminarayan R. Incidence and etiology of clinically-attended, antibiotic-treated diarrhea among children under five years of age in low- and middle-income countries: Evidence from the Global Enteric Multicenter Study. PLoS Negl Trop Dis 2020;14:e0008520. [PMID: 32776938 DOI: 10.1371/journal.pntd.0008520] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
33 Allwell-Brown G, Hussain-Alkhateeb L, Sewe MO, Kitutu FE, Strömdahl S, Mårtensson A, Johansson EW. Determinants of trends in reported antibiotic use among sick children under five years of age across low-income and middle-income countries in 2005-17: A systematic analysis of user characteristics based on 132 national surveys from 73 countries. Int J Infect Dis 2021;108:473-82. [PMID: 34058373 DOI: 10.1016/j.ijid.2021.05.058] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Waddington C, Carey ME, Boinett CJ, Higginson E, Veeraraghavan B, Baker S. Exploiting genomics to mitigate the public health impact of antimicrobial resistance. Genome Med 2022;14:15. [PMID: 35172877 DOI: 10.1186/s13073-022-01020-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Vekemans J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, Fiore A, Tayler E, Klemm EJ, Laxminarayan R, Srikantiah P, Friede M, Lipsitch M. Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework. Clin Infect Dis 2021;73:e1011-7. [PMID: 33493317 DOI: 10.1093/cid/ciab062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
36 Lewnard JA, Fries LF, Cho I, Chen J, Laxminarayan R. Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus. Proc Natl Acad Sci U S A 2022;119:e2112410119. [PMID: 35286196 DOI: 10.1073/pnas.2112410119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
37 Bilgin GM, Lokuge K, Glass K. Modelling the impact of maternal pneumococcal vaccination on infant pneumococcal disease in low-income settings. Vaccine 2022;40:4128-34. [PMID: 35667913 DOI: 10.1016/j.vaccine.2022.05.066] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Wang C, Su L, Mu Q, Gu X, Guo X, Wang X. Cost-effectiveness analysis of domestic 13-valent pneumococcal conjugate vaccine for children under 5 years of age in mainland China. Hum Vaccin Immunother 2021;17:2241-8. [PMID: 33577390 DOI: 10.1080/21645515.2020.1870396] [Reference Citation Analysis]